PG Harper

528 total citations
7 papers, 390 citations indexed

About

PG Harper is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, PG Harper has authored 7 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in PG Harper's work include Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). PG Harper is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). PG Harper collaborates with scholars based in United Kingdom. PG Harper's co-authors include Hannah Quinn, M Partridge, DM Geddes, SG Spiro, Jeffrey Tobias, C. M. Ash, C.J. Twelves, Helena Earl, DM Geddes and ML Slevin and has published in prestigious journals such as British Journal of Cancer and British Journal of Clinical Pharmacology.

In The Last Decade

PG Harper

7 papers receiving 369 citations

Peers

PG Harper

ONCOL

EPIDE

MB

PRM

SURGE

Michael Coutts United Kingdom

Alberto Romero Argentina

Jess Frank United States

Georges Garnier France

Michèle Natale Germany

Yogesh Kembhavi India

Lucía González‐Cortijo Spain

C. A. Meanwell United Kingdom

H.W.H.M. van der Putten Netherlands

Sérgio A. Triginelli Brazil

Michael Coutts United Kingdom

PG Harper

126 ×0.5

ONCOL

105 ×0.6

EPIDE

69 ×0.5

MB

140 ×1.2

PRM

46 ×0.5

SURGE

Citations per year, relative to PG Harper PG Harper (= 1×) peers Michael Coutts

Countries citing papers authored by PG Harper

Since Specialization

Citations

This map shows the geographic impact of PG Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PG Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PG Harper more than expected).

Fields of papers citing papers by PG Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PG Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PG Harper. The network helps show where PG Harper may publish in the future.

Co-authorship network of co-authors of PG Harper

This figure shows the co-authorship network connecting the top 25 collaborators of PG Harper. A scholar is included among the top collaborators of PG Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PG Harper. PG Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mead, Graham M., Mark A. Russell, Peter E. Clark, et al.. (1998). A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. British Journal of Cancer. 78(8). 1067–1075. 66 indexed citations

2.

Gower, N.H., R.M. Rudd, SG Spiro, et al.. (1996). A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial. British Journal of Cancer. 73(12). 1563–1568. 20 indexed citations

3.

Woll, Penella J., D. Crowther, M Soukop, et al.. (1995). Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma. British Journal of Cancer. 72(1). 183–184. 24 indexed citations

4.

Seymour, Michel, et al.. (1994). Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. British Journal of Cancer. 69(1). 191–195. 57 indexed citations

5.

Thatcher, N., et al.. (1991). The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.. British Journal of Clinical Pharmacology. 31(1). 77–82. 21 indexed citations

6.

Twelves, C.J., R L Souhami, PG Harper, et al.. (1990). The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. British Journal of Cancer. 61(1). 147–150. 67 indexed citations

7.

Geddes, DM, et al.. (1989). Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. British Journal of Cancer. 59(4). 578–583. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact